Elf-1 and PU.1 induce expression of gp91(phox) via a promoter element mutated in a subset of chronic granulomatous disease patients

Blood

Volumn 93, Issue 10, 1999, Pages 3512-3520

  Voo, Kui Shin ^a   Skalnik, David G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME B; DNA BINDING PROTEIN;

ARTICLE; BINDING AFFINITY; BONE MARROW CELL; CHRONIC GRANULOMATOUS DISEASE; DNA BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PHAGOCYTE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION;

EID: 0001324766     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.10.3512.410k19_3512_3520     Document Type: Article

References (40)

1. Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, Cole FS, Curnutte JT, Orkin SH: Cloning the gene for an inherited human disorder - chronic granulomatous disease - on the basis of its chromosomal location. Nature 322:32, 1986
2. Babior BM: Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. The respiratory burst oxidase. Curr Opin Hematol 2:55, 1995
3. Lomax KJ, Leto TL, Nunoi H, Galin JI, Malech HL: Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245:409, 1989
4. Barker KA, Orkin SH, Newburger PE: Expression of the X-CGD gene during induced differentiation of myeloid leukemia cell line HL-60. Mol Cell Biol 8:2804, 1988
5. c-src. Science 248:727, 1990
6. Orkin SH: Molecular genetics of chronic granulomatous disease. Annu Rev Immunol 7:277, 1989
7. Skalnik DG, Dorfman DM, Perkins A, Jenkins N, Copeland N, Orkin SH: Targeting of trangene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc Natl Acad Sci USA 88:8505, 1991
8. Eklund EA, Skalnik DG: Characterization of a gp91-phox promoter element that is required for interferon gamma induced transcription. J Biol Chem 270:8267, 1995
9. Eklund EA, Luo W, Skalnik DG: Characterization of three promoter elements and cognate DNA-binding protein(s) necessary for interferon-gamma induction of gp91-phox transcription. J Immunol 157:2418, 1996
10. Luo W, Skalnik DG: CCAAT displacement protein competes with multiple transcriptional activators for binding to four sites in the proximal gp91 -phox promoter. J Biol Chem 271:18203, 1996
11. Luo W, Skalnik DG: Interferon regulatory factor-2 directs transcription from the gp91-phox promoter. J Biol Chem 271:23445, 1996
12. Skalnik DG, Strauss EC, Orkin SH: CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox promoter. J Biol Chem 266:16736, 1991
13. phox in PLB985 myeloid leukemia cells. J Biol Chem 272:9344, 1997
14. Yamit-Hezi A, Levy Z, Neuman S, Nudel U: A Leuconostoclactis protein with homology to ribosomal protein S1 shares common epitopes and common DNA binding properties with a mammalian DNA binding nuclear factor. Gene 185:99, 1997
15. Vanden Heuvel GB, Bodmer R, McConnell KR, Nagami GT, Igarashi P: Expression of a cut-related homeobox gene in developing and polycystic mouse kidney. Kid Int 50:453, 1996
16. Andres V, Nadal-Ginard B, Mahdavi V: Clox, a mammalian homeobox gene related to Drosophila cut, encodes DNA-binding regulatory proteins differentially expressed during development. Development 116:321, 1992
17. Newburger PE, Skalnik DG, Hopkins PJ, Eklund EA, Curnutte JT: Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558. J Clin Invest 94:1205, 1994
18. Suzuki S, Kumatori A, Haagen I-A, Fujii Y, Sadat MA, Jun HL, Tsuji Y, Roos D, Nakamura M: PU.1 as an essential activator for the expression of gp91phox gene in human peripheral neutrophils, monocytes, and B lymphocytes. Proc Natl Acad Sci USA 95:6085, 1998
19. Woodman RC, Newburger PE, Erickson AP, Rae J, Cohen MS, Curnutte JT: A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells. Blood 85:231, 1995
20. Kuribayashi F, Kumatori A, Suzuki S, Nakamura M, Matsumoto T, Tsuji Y: Human peripheral eosinophils have a specific mechanism to express gp91-phox, the large subunit of cytochrome b558. Biochem Biophys Res Commun 209:146, 1995
21. Tucker KA, Lilly MB, Heck L, Rado TA: Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70:372, 1987
22. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mamalian nuclei. Nucleic Acids Res 11:1475, 1983
23. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
24. Orchard K, May GE: An EMSA-based method for determining the molecular weight of a protein-DNA complex. Nucleic Acids Res 21:3335, 1993
25. Kristensen H-H, Valentin-Hansen P, Sogaard-Andersen L: CytR/ cAMP-CRP nucleoprotein formation in E. coli: The CytR repressor binds its operator as a stable dimer in a ternary complex with cAMP-CRP. J Mol Biol 260:113, 1996
26. Wurster AL, Siu G, Leiden J, Hedrick SM: Elf-1 binds to a critical element in a second CD4 enhancer. Mol Cell Biol 14:6452, 1994
27. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA: The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113, 1990
28. Andres V, Chiara MD, Mahdavi V: A new bipartite DNA-binding domain: Cooperative interaction between the cut repeat and homeo domain of the cut homeo proteins. Genes Dev 8:245, 1994
29. Nordeen SK: Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454, 1988
30. Hilfinger JM, Clark N, Smith M, Robinson K, Markovitz DM: Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation. J Virol 67:4448, 1993
31. Thompson CB, Wang C-Y, Ho I-C, Bohianen PR, Petrvniak B, June CH, Miesfeldt S, Zhang L, Nabel GJ, Karpinski B, Leiden JM: Cis-acting sequences are required for inducible interleukin-2 enhancer function bind a novel ets-related protein, Elf-1. Mol Cell Biol 12:1043, 1992
32. Rossmarin AG, Caprio D, Levy R, Simkevich C: CD18 (b2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. Proc Natl Acad Sci USA 92:801, 1995
33. Chen H-M, Zhang P, Voso MT, Hohaus S, Gonzalez DA, Glass CK, Zhang E-E, Tenen DG: Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85:2918, 1995
34. Davis JN, Roussel MF: Cloning and expression of the murine Elf-1 cDNA. Gene 171:265, 1996
35. Heydeman A, Juang G, Hennessy K, Parmacek MS, Simon MC: The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol Cell Biol 16:1676, 1996
36. Anderson KL, Smith KA, Pio F, Torbett BE, Maki RA: Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood 92:1576, 1998
37. Lievens PMJ, Donady JJ, Tufareli C, Neufeld EJ: Repressor activity of CCAAT displacement protein in HL60 myeloid leukemia cells. J Biol Chem 270:12745, 1995
38. phox promoter activity in myeloid cells. J Biol Chem 272:17802, 1997
39. Eklund EA, Jalava A, Kakar R: PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91phox expression. J Biol Chem 273:13957, 1998
40. Hromas R, Orazi A, Reiman RS, Maki R, Van Beveran C, Moore J, Klemsz M: Hematopoietic lineage-and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82:2998, 1993